EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Evaluation, Diagnosis, and Management of Infantile Hemangiomas—A Comprehensive Review

Arnes Rešić, Zoran Barčot, Dubravko Habek iD, Zenon Pogorelić iD, Marko Bašković iD

Journal of Clinical Medicine · 10.01.2025 · 14 (2) · 425

DOI: 10.3390/jcm14020425 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 10.01.2025. Verfasst von Arnes Rešić und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Children's Hospital Zagreb, Ulica Vjekoslava Klaića 16, 10000 Zagreb, Croatia. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 202 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infantile hemangioma (IH) is the most common pediatric benign vascular tumor. Its pathogenesis is still poorly understood, and it usually appears during the first few weeks of life and follows a characteristic natural course of proliferation and involution. Most IHs are small, benign, resolve spontaneously, and do not require active treatment but only active observation. A minority of IHs are potentially problematic because they can cause life-threatening complications, permanent disfigurement, and functional impairment. Diagnosis is usually clinical, and propranolol is currently the mainstay of treatment. Other therapeutic modalities may be used alone or in combination, depending on the characteristics of the specific IH. New treatment options are being explored every day, and some are showing promising results. It is undeniable that therapeutic modalities for IHs must be selected based on the child’s age, the size and location of the lesion, the presence of complications, the implementation conditions, and the possible outcomes of the treatment. The future of IH management will certainly be reflected in improved advanced imaging modalities, research into the genetic and molecular basis, the development of new pharmacological agents or techniques, and the development of standardized protocols, all to optimize outcomes with minimal side effects.

Schlagwörter

Stichwörter der Autor:innen

childreninfantinfantile hemangiomalaser therapypropranololsurgerytimololvascular tumorβ-blockers

Autor:innen und Institutionen

  • Department of Pediatrics, Children's Hospital Zagreb, Ulica Vjekoslava Klaića 16, 10000 Zagreb, Croatia.
  • University Department of Health Studies, University of Split, Ruđera Boškovića 35, 21000 Split, Croatia.
  • Department of Pediatric Surgery, Children's Hospital Zagreb, Ulica Vjekoslava Klaića 16, 10000 Zagreb, Croatia.
  • School of Medicine, University of Zagreb, Šalata 3, 10000 Zagreb, Croatia.
  • Croatian Academy of Medical Sciences, Kaptol 15, 10000 Zagreb, Croatia.
  • Department of Obstetrics and Gynecology, Clinical Hospital Merkur, Zajčeva ulica 19, 10000 Zagreb, Croatia.

ORCID-Profile: Dubravko Habek, Zenon Pogorelić, Marko Bašković

Zitieren

APA

Rešić, A., Barčot, Z., Habek, D., Pogorelić, Z., & Bašković, M. (2025). The Evaluation, Diagnosis, and Management of Infantile Hemangiomas—A Comprehensive Review. Journal of Clinical Medicine, 14(2), 425. https://doi.org/10.3390/jcm14020425

Vancouver

Rešić A, Barčot Z, Habek D, Pogorelić Z, Bašković M. The Evaluation, Diagnosis, and Management of Infantile Hemangiomas—A Comprehensive Review. Journal of Clinical Medicine. 2025;14(2):425. doi:10.3390/jcm14020425

BibTeX
@article{Rei2025,
  author = {Rešić, Arnes and Barčot, Zoran and Habek, Dubravko and Pogorelić, Zenon and Bašković, Marko},
  title = {The Evaluation, Diagnosis, and Management of Infantile Hemangiomas—A Comprehensive Review},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {2},
  pages = {425},
  doi = {10.3390/jcm14020425}
}
Kostenlos starten →